OPKO Health, Inc. Revenue, Net (Deprecated 2018-01-31)
OPKO Health, Inc. (OPK) reported Revenue, Net (Deprecated 2018-01-31) of $254.91 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2019-01-29
- OPKO Health, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $254.91M, a 4.31% decline year-over-year.
- OPKO Health, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $160.98M, a 34.80% decline year-over-year.
- OPKO Health, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $246.04M, a 8.65% decline year-over-year.
- OPKO Health, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $292.60M, a 11.95% decline year-over-year.
- OPKO Health, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $91.13M, a 5.60% decline from fiscal 2013.
- OPKO Health, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2013 was $96.53M, a 105.19% increase from fiscal 2012.
- OPKO Health, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2012 was $47.04M, a 68.14% increase from fiscal 2011.
- OPKO Health, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2011 was $27.98M, a 1.81% decline from fiscal 2010.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | $254.91M 10-Q · filed 2018-05-08 | $415.90M derived: sum of 2 quarters · filed 2019-01-29 | $661.94M derived: sum of 3 quarters · filed 2019-01-29 | $954.54M derived: sum of 4 quarters · filed 2019-01-29 | |||
| 2017-12-31 | $160.98M 8-K · filed 2019-01-29 | $193.70M 10-K · filed 2018-03-01 | $407.02M derived: sum of 2 quarters · filed 2019-01-29 | $699.62M derived: sum of 3 quarters · filed 2019-01-29 | $966.01M 8-K · filed 2019-01-29 | $1.07B 10-K · filed 2018-03-01 | |
| 2017-09-30 | $246.04M 8-K · filed 2019-01-29 | $263.50M 10-Q · filed 2017-11-08 | $538.64M derived: sum of 2 quarters · filed 2019-01-29 | $873.80M 10-Q · filed 2017-11-08 | $1.05B derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-06-30 | $292.60M 8-K · filed 2019-01-29 | $314.21M 10-Q · filed 2017-08-08 | $610.31M 10-Q · filed 2017-08-08 | $805.88M derived: sum of 3 quarters · filed 2019-01-29 | $1.08B derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-03-31 | $266.38M 8-K · filed 2019-01-29 | $296.10M 10-Q · filed 2017-05-10 | $513.27M derived: sum of 2 quarters · filed 2019-01-29 | $782.61M derived: sum of 3 quarters · filed 2019-01-29 | $1.11B derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-12-31 | $246.89M 8-K · filed 2019-01-29 | $275.49M 10-K · filed 2017-03-01 | $516.22M derived: sum of 2 quarters · filed 2019-01-29 | $848.54M derived: sum of 3 quarters · filed 2019-01-29 | $1.12B 8-K · filed 2019-01-29 | $1.22B 10-K · filed 2017-03-01 | |
| 2016-09-30 | $269.33M 8-K · filed 2019-01-29 | $298.04M 10-Q · filed 2016-11-07 | $601.65M derived: sum of 2 quarters · filed 2019-01-29 | $946.17M 10-Q · filed 2017-11-08 | $1.15B derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-06-30 | $332.32M 8-K · filed 2019-01-29 | $357.10M 10-Q · filed 2016-08-08 | $648.14M 10-Q · filed 2017-08-08 | $877.46M derived: sum of 3 quarters · filed 2019-01-29 | $1.02B derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-03-31 | $268.95M 8-K · filed 2019-01-29 | $291.04M 10-Q · filed 2016-05-09 | $545.14M derived: sum of 2 quarters · filed 2019-01-29 | $688.17M derived: sum of 3 quarters · filed 2019-01-29 | $730.60M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2015-12-31 | $276.19M 10-K · filed 2017-03-01 | $419.23M derived: sum of 2 quarters · filed 2017-03-01 | $461.65M derived: sum of 3 quarters · filed 2017-03-01 | $447.52M 8-K · filed 2019-01-29 | $491.74M 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $143.03M 10-K · filed 2017-03-01 | $185.46M derived: sum of 2 quarters · filed 2017-03-01 | $215.55M 10-Q · filed 2016-11-07 | $241.08M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $42.43M 10-K · filed 2017-03-01 | $72.51M 10-Q · filed 2016-08-08 | $98.05M derived: sum of 3 quarters · filed 2017-03-01 | $117.82M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $30.08M 10-K · filed 2017-03-01 | $55.62M derived: sum of 2 quarters · filed 2017-03-01 | $75.39M derived: sum of 3 quarters · filed 2017-03-01 | $98.94M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $25.53M 10-K · filed 2016-02-29 | $45.31M derived: sum of 2 quarters · filed 2016-02-29 | $68.85M derived: sum of 3 quarters · filed 2016-02-29 | $91.13M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $19.77M 10-K · filed 2016-02-29 | $43.32M derived: sum of 2 quarters · filed 2016-02-29 | $65.59M 10-Q · filed 2015-11-09 | $86.28M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $23.55M 10-K · filed 2016-02-29 | $45.82M 10-Q · filed 2015-08-05 | $66.51M derived: sum of 3 quarters · filed 2016-02-29 | $87.15M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $22.27M 10-K · filed 2016-02-29 | $42.97M derived: sum of 2 quarters · filed 2016-02-29 | $63.61M derived: sum of 3 quarters · filed 2016-02-29 | $87.43M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $20.69M 10-K · filed 2015-02-27 | $41.33M derived: sum of 2 quarters · filed 2015-02-27 | $65.15M derived: sum of 3 quarters · filed 2015-02-27 | $96.53M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $20.64M 10-K · filed 2015-02-27 | $44.46M derived: sum of 2 quarters · filed 2015-02-27 | $75.84M 10-Q · filed 2014-11-07 | $92.10M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | $23.82M 10-K · filed 2015-02-27 | $55.20M 10-Q · filed 2014-08-11 | $71.46M derived: sum of 3 quarters · filed 2015-02-27 | $83.25M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | $31.38M 10-K · filed 2015-02-27 | $47.64M derived: sum of 2 quarters · filed 2015-02-27 | $59.43M derived: sum of 3 quarters · filed 2015-02-27 | $69.64M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $16.26M 10-K · filed 2014-03-03 | $28.06M derived: sum of 2 quarters · filed 2014-03-03 | $38.27M derived: sum of 3 quarters · filed 2014-03-03 | $47.04M 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $11.79M 10-K · filed 2014-03-03 | $22.01M derived: sum of 2 quarters · filed 2014-03-03 | $30.78M 10-Q · filed 2013-11-12 | $36.58M derived: sum of 4 quarters · filed 2014-03-03 | |||
| 2012-06-30 | $10.21M 10-K · filed 2014-03-03 | $18.99M 10-Q · filed 2013-08-09 | $24.78M derived: sum of 3 quarters · filed 2014-03-03 | $31.59M derived: sum of 4 quarters · filed 2014-03-03 | |||
| 2012-03-31 | $8.78M 10-K · filed 2014-03-03 | $14.57M derived: sum of 2 quarters · filed 2014-03-03 | $21.38M derived: sum of 3 quarters · filed 2014-03-03 | $29.81M derived: sum of 4 quarters · filed 2014-03-03 | |||
| 2011-12-31 | $5.79M 10-K · filed 2013-03-18 | $12.60M derived: sum of 2 quarters · filed 2013-03-18 | $21.03M derived: sum of 3 quarters · filed 2013-03-18 | $27.98M 10-K · filed 2014-03-03 | |||
| 2011-09-30 | $6.81M 10-K · filed 2013-03-18 | $15.23M derived: sum of 2 quarters · filed 2013-03-18 | $22.18M 10-Q · filed 2012-11-09 | $34.42M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | $8.43M 10-K · filed 2013-03-18 | $10.14M 10-Q · filed 2011-08-08 | $15.38M 10-Q · filed 2012-08-09 | $18.79M 10-Q · filed 2011-08-08 | $27.61M derived: sum of 3 quarters · filed 2013-03-18 | $33.29M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $6.95M 10-K · filed 2013-03-18 | $19.18M derived: sum of 2 quarters · filed 2013-03-18 | $24.86M derived: sum of 3 quarters · filed 2013-03-18 | $32.31M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $12.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $17.91M derived: sum of 2 quarters · filed 2013-03-18 | $25.36M derived: sum of 3 quarters · filed 2013-03-18 | $28.49M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | $5.68M 10-Q · filed 2011-11-09 | $13.13M derived: sum of 2 quarters · filed 2011-11-09 | $16.26M 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $7.46M 10-Q · filed 2011-08-08 | $15.38M 10-Q · filed 2011-08-08 | |||||
| 2009-12-31 | $4.42M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |